{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:31:18Z","timestamp":1786984278307,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ahj.2019.08.010","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T10:50:24Z","timestamp":1566039024000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["The subcutaneous implantable cardioverter-defibrillator in review"],"prefix":"10.1016","volume":"217","author":[{"given":"Nicholas J","family":"Kamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana M","family":"Al-Khatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2019.08.010_bb0005","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics\u20142018 Update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.08.010_bb0010","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1016\/j.jacc.2017.10.054","volume":"72","author":"Al-Khatib","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0015","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.110.959734","article-title":"Risk stratification for arrhythmic sudden cardiac death: identifying the roadblocks","volume":"123","author":"Goldberger","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.08.010_bb0020","doi-asserted-by":"crossref","unstructured":"Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. The New England journal of medicine Dec 26 1996;335:1933\u20131940.","DOI":"10.1056\/NEJM199612263352601"},{"key":"10.1016\/j.ahj.2019.08.010_bb0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.08.010_bb0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.jacc.2011.06.007","article-title":"Implantation-related complications of implantable cardioverter-defibrillators and cardiac resynchronization therapy devices: a systematic review of randomized clinical trials","volume":"58","author":"van Rees","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0035","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.663807","article-title":"Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years","volume":"115","author":"Kleemann","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.08.010_bb0040","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejim.2017.09.038","article-title":"Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry","volume":"48","author":"Sponder","year":"2018","journal-title":"Eur J Intern Med Feb"},{"key":"10.1016\/j.ahj.2019.08.010_bb0045","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/pace.13314","article-title":"Subcutaneous ICD screening with the Boston Scientific ZOOM programmer versus a 12-lead ECG machine","volume":"41","author":"Chang","year":"2018","journal-title":"Pacing and clinical electrophysiology : PACE May"},{"key":"10.1016\/j.ahj.2019.08.010_bb0050","article-title":"Implantation of the subcutaneous implantable cardioverter-defibrillator: an evaluation of 4 implantation techniques","volume":"10","author":"Brouwer","year":"2017","journal-title":"Circulation Arrhythmia and electrophysiology Jan"},{"key":"10.1016\/j.ahj.2019.08.010_bb0055","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.jacc.2012.06.053","article-title":"The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort","volume":"60","author":"Olde Nordkamp","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0060","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.hrthm.2013.05.016","article-title":"Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator","volume":"10","author":"Knops","year":"2013","journal-title":"Heart rhythm Aug"},{"key":"10.1016\/j.ahj.2019.08.010_bb0065","doi-asserted-by":"crossref","unstructured":"Quast ABE, Brouwer TF, Tjong FVY, Wilde AAM, Knops RE. Clinical parameters to optimize patient selection for subcutaneous and transvenous implantable defibrillator therapy. Pacing and clinical electrophysiology : PACE Jun 13 2018.","DOI":"10.1111\/pace.13411"},{"key":"10.1016\/j.ahj.2019.08.010_bb0070","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1001\/jamacardio.2016.2782","article-title":"Trends and in-hospital outcomes associated with adoption of the subcutaneous implantable cardioverter defibrillator in the United States","volume":"1","author":"Friedman","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0075","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCULATIONAHA.113.003042","article-title":"Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillator","volume":"128","author":"Weiss","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2019.08.010_bb0080","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/eurheartj\/ehu112","article-title":"Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry","volume":"35","author":"Lambiase","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.08.010_bb0085","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.jacc.2015.02.047","article-title":"Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE Study and EFFORTLESS Registry","volume":"65","author":"Burke","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0090","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hrthm.2016.11.025","article-title":"Performance of the subcutaneous implantable cardioverter-defibrillator in patients with a primary prevention indication with and without a reduced ejection fraction versus patients with a secondary prevention indication","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart rhythm Mar"},{"key":"10.1016\/j.ahj.2019.08.010_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.hrthm.2015.08.039","article-title":"Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction","volume":"13","author":"Boersma","year":"2016","journal-title":"Heart rhythm Jan"},{"key":"10.1016\/j.ahj.2019.08.010_bb0100","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jacc.2017.06.040","article-title":"Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study","volume":"70","author":"Boersma","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0105","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.hrthm.2017.05.016","article-title":"Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: clinical characteristics and perioperative results","volume":"14","author":"Gold","year":"2017","journal-title":"Heart rhythm Oct"},{"key":"10.1016\/j.ahj.2019.08.010_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa0909545","article-title":"An entirely subcutaneous implantable cardioverter-defibrillator","volume":"363","author":"Bardy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2019.08.010_bb0115","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/europace\/euv299","article-title":"The learning curve associated with the introduction of the subcutaneous implantable defibrillator","volume":"18","author":"Knops","year":"2016","journal-title":"Europace Jul"},{"key":"10.1016\/j.ahj.2019.08.010_bb0120","doi-asserted-by":"crossref","unstructured":"Peddareddy L, Merchant FM, Leon AR, Smith P, Patel A, El-Chami MF. Effect of defibrillation threshold testing on effectiveness of the subcutaneous implantable cardioverter defibrillator. Pacing and clinical electrophysiology : PACE Jun 12 2018.","DOI":"10.1111\/pace.13416"},{"key":"10.1016\/j.ahj.2019.08.010_bb0125","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(14)61903-6","article-title":"Cardioverter defibrillator implantation without induction of ventricular fibrillation: a single-blind, non-inferiority, randomised controlled trial (SIMPLE)","volume":"385","author":"Healey","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2019.08.010_bb0130","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1093\/eurheartj\/ehv292","article-title":"Intra-operative defibrillation testing and clinical shock efficacy in patients with implantable cardioverter-defibrillators: the NORDIC ICD randomized clinical trial","volume":"36","author":"Bansch","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2019.08.010_bb0135","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1016\/j.hrthm.2015.11.018","article-title":"2015 HRS\/EHRA\/APHRS\/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing","volume":"13","author":"Wilkoff","year":"2016","journal-title":"Heart rhythm Feb"},{"key":"10.1016\/j.ahj.2019.08.010_bb0140","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jacep.2017.11.019","article-title":"Impact of body mass index on safety and efficacy of the subcutaneous implantable cardioverter-defibrillator","volume":"4","author":"Frankel","year":"2018","journal-title":"JACC Clin Electrophysiol May"},{"key":"10.1016\/j.ahj.2019.08.010_bb0145","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29\u2013Identifier NCT03495297, a randomised trial of S-ICD implantation with and without defibrillation testing (PRAETORIAN-DFT) 2018 April 12 [cited 2018 October 5]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03495297."},{"key":"10.1016\/j.ahj.2019.08.010_bb0150","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacep.2017.07.017","article-title":"Subcutaneous versus transvenous implantable defibrillator therapy: a meta-analysis of case-control studies","volume":"3","author":"Basu-Ray","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0155","doi-asserted-by":"crossref","first-page":"f240","DOI":"10.1093\/europace\/euy083","article-title":"Propensity score matched comparison of subcutaneous and transvenous implantable cardioverter-defibrillator therapy in the SIMPLE and EFFORTLESS studies","volume":"20","author":"Brouwer","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2019.08.010_bb0160","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1093\/europace\/euy092","volume":"20","author":"Lenarczyk","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2019.08.010_bb0165","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.jacc.2016.08.044","article-title":"Long-term clinical outcomes of subcutaneous versus transvenous implantable defibrillator therapy","volume":"68","author":"Brouwer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2019.08.010_bb0170","doi-asserted-by":"crossref","unstructured":"Mithani A, Kath H, Eno E, Nathan K, Field J, Hunter K, Ortman M, Andriulli J, Russo A. Characteristics and clinical outcomes of patients undergoing subcutaneous versus transvenous single chamber ICD placement. Journal of the American College of Cardiology 2016\/04\/05\/ 2016;67:860.","DOI":"10.1016\/S0735-1097(16)30861-0"},{"key":"10.1016\/j.ahj.2019.08.010_bb0175","doi-asserted-by":"crossref","unstructured":"Baalman SWE, Quast ABE, Brouwer TF, Knops RE. An overview of clinical outcomes in transvenous and subcutaneous ICD patients. Curr Cardiol Rep Jul 10 2018;20:72.","DOI":"10.1007\/s11886-018-1021-8"},{"key":"10.1016\/j.ahj.2019.08.010_bb0180","doi-asserted-by":"crossref","unstructured":"Honarbakhsh S, Providencia R, Srinivasan N, et al. A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. Int J Cardiol Feb 1 2017;228:280\u2013285.","DOI":"10.1016\/j.ijcard.2016.11.017"},{"key":"10.1016\/j.ahj.2019.08.010_bb0185","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hrthm.2012.09.126","article-title":"Implantation and follow-up of totally subcutaneous versus conventional implantable cardioverter-defibrillators: a multicenter case-control study","volume":"10","author":"Kobe","year":"2013","journal-title":"Heart rhythm Jan"},{"key":"10.1016\/j.ahj.2019.08.010_bb0190","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/europace\/eux026","article-title":"Characteristics and early clinical outcomes of patients undergoing totally subcutaneous vs. transvenous single chamber implantable cardioverter defibrillator placement","volume":"20","author":"Mithani","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.ahj.2019.08.010_bb0195","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.hrthm.2009.05.020","article-title":"Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA)","volume":"6","author":"Wilkoff","year":"2009","journal-title":"Heart rhythm Jul"},{"key":"10.1016\/j.ahj.2019.08.010_bb0200","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/pace.13481","article-title":"Removal of subcutaneous defibrillator shocking coils: lessons to learn for future extraction of subcutaneous defibrillator systems","volume":"41","author":"Nakhla","year":"2018","journal-title":"Pacing and clinical electrophysiology : PACE Oct"},{"key":"10.1016\/j.ahj.2019.08.010_bb0205","doi-asserted-by":"crossref","unstructured":"Olde Nordkamp LR, Knops RE, Bardy GH, et al. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy. Am Heart J May 2012;163:753\u2013760.e752.","DOI":"10.1016\/j.ahj.2012.02.012"},{"key":"10.1016\/j.ahj.2019.08.010_bb0210","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29\u2013identifier NCT02881255, avoid transvenous leads in appropriate subjects (ATLAS S-ICD) 2016 Aug 6 [cited 2018 October 5] Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/study\/NCT02881255."},{"key":"10.1016\/j.ahj.2019.08.010_bb0215","unstructured":"ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 Feb 29\u2013identifier NCT02433379, understanding outcomes with the EMBLEM\u2122 S-ICD in primary prevention patients with low ejection fraction (UNTOUCHED) 2015 May 5 [cited 2018 October 5] Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02433379."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031930208X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000287031930208X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:03:47Z","timestamp":1757570627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000287031930208X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"alternative-id":["S000287031930208X"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.08.010","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The subcutaneous implantable cardioverter-defibrillator in review","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}